Evrima transforms the recruitment process for clinical trials to help clinicians accelerate timelines and increase patient awareness.
Evrima Technologies has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in September 2022.
Evrima Technologies's investors include Wavemaker Ventures, Artesian VC, BridgeLane Capital.
Evrima Technologies is headquartered in Leichhardt, Australia.
Evrima transforms the recruitment process for clinical trials to help clinicians accelerate timelines and increase patient awareness.
Evrima Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Evrima Technologies — Funding & Investors." VCBacked, September 5, 2022, https://www.vcbacked.co/company/evrima-technologies. Accessed October 22, 2026.
VCBacked. (2022). Evrima Technologies — Funding & Investors. Retrieved October 22, 2026, from https://www.vcbacked.co/company/evrima-technologies
{{cite web |title=Evrima Technologies — Funding & Investors |url=https://www.vcbacked.co/company/evrima-technologies |website=VCBacked |access-date=October 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated